Skip to content

Devon K. Check, PhD

Kaiser Permanente Researcher Profiles

Devon Check, PhD, is an adjunt investigator at the Kaiser Permanente Northern California Division of Research. Devon received her bachelor’s degree in History and Spanish from the University of Virginia, and her PhD in Health Policy and Management from the University of North Carolina at Chapel Hill. During her PhD program, she was supported by a National Cancer Institute-sponsored traineeship in cancer care quality research. Her dissertation investigated racial disparities in the quality of chemotherapy-induced side effect management among women being treated for breast cancer. Dr. Check’s current research focuses broadly on improving the quality, value, and equity of cancer care.


Appropriate Use of Antiemetics to Prevent Chemotherapy-Induced Nausea and Vomiting

Authors: Check DK; Basch EM

JAMA Oncol. 2017 03 01;3(3):307-309.

PubMed abstract

Examining racial variation in antiemetic use and post-chemotherapy health care utilization for nausea and vomiting among breast cancer patients

Authors: Check DK; Reeder-Hayes KE; Zullig LL; Weinberger M; Basch EM; Dusetzina SB

Support Care Cancer. 2016 Dec;24(12):4839-4847. Epub 2016-07-27.

PubMed abstract

Parenting concerns, quality of life, and psychological distress in patients with advanced cancer

Authors: Park EM; Deal AM; Check DK; Hanson LC; Reeder-Hayes KE; Mayer DK; Yopp JM; Song MK; Muriel AC; Rosenstein DL

​Psychooncology. 2016 Aug;25(8):942-8. doi: 10.1002/pon.3935. Epub 2015 Aug 17.

PubMed abstract

Early supportive medication use and end-of-life care among Medicare beneficiaries with advanced breast cancer

Authors: Check DK; Rosenstein DL; Dusetzina SB

​Support Care Cancer. 2016 Aug;24(8):3463-72. doi: 10.1007/s00520-016-3174-6. Epub 2016 Mar 19.

PubMed abstract

Investigation of Racial Disparities in Early Supportive Medication Use and End-of-Life Care Among Medicare Beneficiaries With Stage IV Breast Cancer

Authors: Check DK; Samuel CA; Rosenstein DL; Dusetzina SB

​J Clin Oncol. 2016 Jul 1;34(19):2265-70. doi: 10.1200/JCO.2015.64.8162. Epub 2016 May 9.

PubMed abstract

Concerns underlying treatment preferences of advanced cancer patients with children

Authors: Check DK; Park EM; Reeder-Hayes KE; Mayer DK; Deal AM; Yopp JM; Rosenstein DL; Hanson LC

​Psychooncology. 2016 May 26. doi: 10.1002/pon.4164. [Epub ahead of print]

PubMed abstract

Investigating racial disparities in use of NK1 receptor antagonists to prevent chemotherapy-induced nausea and vomiting among women with breast cancer

Authors: Check DK; Reeder-Hayes KE; Basch EM; Zullig LL; Weinberger M; Dusetzina SB

​Breast Cancer Res Treat. 2016 Apr;156(2):351-9. doi: 10.1007/s10549-016-3747-6. Epub 2016 Mar 11.

PubMed abstract

An exploratory study of end-of-life prognostic communication needs as reported by widowed fathers due to cancer

Authors: Park EM; Check DK; Yopp JM; Deal AM; Edwards TP; Rosenstein DL

​Psychooncology. 2015 Nov;24(11):1471-6. doi: 10.1002/pon.3757. Epub 2015 Feb 6.

PubMed abstract

Is there a role for survivorship care plans in advanced cancer?

Authors: Mayer DK; Green M; Check DK; Gerstel A; Chen RC; Asher G; Wheeler SB; Hanson LC; Rosenstein DL

​Support Care Cancer. 2015 Aug;23(8):2225-30. doi: 10.1007/s00520-014-2586-4. Epub 2015 Jan 7.

PubMed abstract

Summing it up: an integrative review of studies of cancer survivorship care plans (2006-2013)

Authors: Mayer DK; Birken SA; Check DK; Chen RC

​Cancer. 2015 Apr 1;121(7):978-96. doi: 10.1002/cncr.28884. Epub 2014 Sep 23.

PubMed abstract

Back To Top